The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic

SIMON ROGERS, Anastasios Kanatas

Research output: Contribution to journalArticle

2 Citations (Scopus)
2 Downloads (Pure)

Abstract

The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI.

Original languageEnglish
Pages (from-to)2141-2145
Number of pages5
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume277
Issue number7
Early online date27 Apr 2020
DOIs
Publication statusPublished - 1 Jul 2020
Externally publishedYes

Keywords

  • Patient Concerns Inventory; Head and neck cancer; SARS-CoV-2; Coronovirus
  • SARS-CoV-2
  • Coronavirus
  • Head and neck cancer
  • Patient concerns inventory
  • Head and Neck Neoplasms/diagnosis
  • Humans
  • Coronavirus Infections/epidemiology
  • Pandemics/prevention & control
  • Health Services Needs and Demand
  • Pneumonia, Viral/epidemiology
  • Betacoronavirus
  • Checklist
  • Quality of Life

Fingerprint Dive into the research topics of 'The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic'. Together they form a unique fingerprint.

  • Cite this